BR112021018124A2 - Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína - Google Patents

Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína

Info

Publication number
BR112021018124A2
BR112021018124A2 BR112021018124A BR112021018124A BR112021018124A2 BR 112021018124 A2 BR112021018124 A2 BR 112021018124A2 BR 112021018124 A BR112021018124 A BR 112021018124A BR 112021018124 A BR112021018124 A BR 112021018124A BR 112021018124 A2 BR112021018124 A2 BR 112021018124A2
Authority
BR
Brazil
Prior art keywords
cell line
selection marker
protein production
production
dhodh
Prior art date
Application number
BR112021018124A
Other languages
English (en)
Portuguese (pt)
Inventor
Louis DUMAS Bruno
Nabil LOUNIS Mohammed
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BR112021018124A2 publication Critical patent/BR112021018124A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BR112021018124A 2019-03-19 2020-03-19 Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína BR112021018124A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305331 2019-03-19
PCT/EP2020/057583 WO2020188021A1 (en) 2019-03-19 2020-03-19 Novel selection marker-comprising cell line and uses thereof for protein production

Publications (1)

Publication Number Publication Date
BR112021018124A2 true BR112021018124A2 (pt) 2021-11-16

Family

ID=66001151

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021018124A BR112021018124A2 (pt) 2019-03-19 2020-03-19 Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína

Country Status (14)

Country Link
US (1) US12529071B2 (cg-RX-API-DMAC7.html)
EP (1) EP3942054A1 (cg-RX-API-DMAC7.html)
JP (1) JP7609795B2 (cg-RX-API-DMAC7.html)
KR (1) KR102976749B1 (cg-RX-API-DMAC7.html)
CN (1) CN113811615B (cg-RX-API-DMAC7.html)
AU (1) AU2020242966B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021018124A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134116A1 (cg-RX-API-DMAC7.html)
IL (1) IL286419A (cg-RX-API-DMAC7.html)
MX (1) MX2021011303A (cg-RX-API-DMAC7.html)
SG (1) SG11202110105UA (cg-RX-API-DMAC7.html)
TW (1) TWI881970B (cg-RX-API-DMAC7.html)
WO (1) WO2020188021A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202106718B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI912369B (zh) * 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
EP2022855B1 (en) 2006-05-16 2015-08-19 Daiichi Sankyo Company, Limited High secretion production method of protein
WO2012027533A1 (en) * 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
RU2556816C1 (ru) 2014-03-12 2015-07-20 Открытое акционерное общество "Фармацевтический импорт, экспорт" (ОАО "Фармимэкс") Штамм клеток яичников китайского хомячка - продуцент рекомбинантного антитела против фактора некроза опухоли альфа человека
CA2965202C (en) * 2014-10-23 2023-02-28 Sanofi Novel selection marker for cell transfection and protein production
EP3344243B1 (en) * 2015-09-01 2020-12-09 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
WO2017117006A1 (en) * 2015-12-29 2017-07-06 The Board Of Trustees Of The Leland Stanford Junior University Use of a dhodh inhibitor in combination with an inhibitor of pyrimidine salvage
CN109777837A (zh) 2018-12-26 2019-05-21 首都医科大学 一种利用CRISPR/Cas9系统构建致死基因全身性敲除小鼠模型的方法
TWI912369B (zh) 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Also Published As

Publication number Publication date
MX2021011303A (es) 2021-10-22
CN113811615B (zh) 2025-11-11
CA3134116A1 (en) 2020-09-24
IL286419A (en) 2021-10-31
AU2020242966A1 (en) 2021-10-21
ZA202106718B (en) 2023-04-26
US12529071B2 (en) 2026-01-20
AU2020242966B2 (en) 2025-09-25
US20220177909A1 (en) 2022-06-09
JP7609795B2 (ja) 2025-01-07
EP3942054A1 (en) 2022-01-26
SG11202110105UA (en) 2021-10-28
CN113811615A (zh) 2021-12-17
TW202102669A (zh) 2021-01-16
TWI881970B (zh) 2025-05-01
KR102976749B1 (ko) 2026-06-15
WO2020188021A1 (en) 2020-09-24
KR20210141511A (ko) 2021-11-23
JP2022526497A (ja) 2022-05-25

Similar Documents

Publication Publication Date Title
CO2022016595A2 (es) Nuevas proteinas de unión a repeticiones de anquirina y sus usos
BR112022021789A2 (pt) Bibliotecas de ácido nucléico variantes para coronavírus
BR112019005964A2 (pt) proteínas de fusão imunomoduladoras
BR112022003241A2 (pt) Fontes de proteína não animal com propriedades fucionais
BR112016014810A2 (pt) Antagonistas de fcrn e métodos de uso
BR112021025130A2 (pt) Reagentes e métodos para replicação, transcrição e tradução em organismos semissintéticos
CO2021008997A2 (es) Constructos de arni para inhibir la expresión de pnpla3 y métodos de uso de estos
MX2021007241A (es) Acido ribonucleico (arn) que codifica para una proteina.
MX2021014649A (es) Dominio de repetición de anquirina diseñado con estabilidad mejorada.
BR112022024501A2 (pt) Construtos de rnai para inibir a expressão de hsd17b13 e métodos de uso dos mesmos
BR112013008407A2 (pt) antígenos de clostridium difficile
BR112019004770A2 (pt) anticorpos do vírus antidengue, polipeptídeos contendo regiões fc variantes, e métodos de uso
BR112017001463A2 (pt) célula hospedeira melhorada para produzir proteínas
AR118536A1 (es) Composiciones y métodos para estabilizar formulaciones que contienen proteína
WO2021130537A3 (en) Compositions and methods for simultaneously modulating expression of genes
MX2021002250A (es) Dominio de nucleasa novedoso y uso del mismo.
BR112022018491A2 (pt) Marcadores de superfície celular recombinante
BR112023020920A2 (pt) Composição de hidrolisado de células de células cultivadas e aplicações da mesma
BR112023003468A2 (pt) Variantes de uma xiloglucanase da família 44
MX2018003445A (es) Expresion de proteinas que contienen fc.
WO2020168151A3 (en) Quantitative mapping of chromatin associated proteins
BR112021010338A2 (pt) Células hospedeiras fúngicas filamentosas modificadas
BR112022026248A2 (pt) Conjugados de citocinas
BR112023005002A2 (pt) Geração de linhagem de células de ovário de hamster chinês recombinantes de alta produção para produção de proteína terapêutica
AR123756A1 (es) Construcciones de ácidos nucléicos, vectores virales y partículas virales

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]